



















The Pharmaceutical & Biotech Industry Automation and Software Expenditures global market research study delivers five year history plus five year market forecast.
This research examines the market for automation products and systems in pharmaceutical and biotech clinical trials and commercial manufacturing and the factors contributing to the growth and deployment of specific products and systems.
Automation products and systems include enterprise asset management, general motion control, LIMS, AC drives, plant asset management, PLCs, DCS, process safety systems, HMIs, field transmitters and valves, process engineering tools, real-time process optimization, production management.
Much of the current automation focuses on projects with immediate return on investments, projects that are the result of consolidation of manufacturing operations, standardization of applications across the entire enterprise, new multi-product biotech processing lines, and product serialization.
Improving new drug pipelines through mergers, acquisitions, and alliances and simplifying supply chains to improve drug security and lower costs negatively impact the growth of automation products and systems. However, the industry is healthy and global demand for branded, generic, and OTC drug products remains strong.
This market study may be purchased as an Excel Workbook.
MIRA Workbook | PDF File | |
Worldwide (includes regional data) | Yes | No |
The research identifies all relevant suppliers serving this market.